App-Based study tracks quality of life in melanoma patients on targeted therapy
Knowledge-focused
Ongoing
This study follows 50 adults in the UK with advanced BRAF V600 mutation-positive melanoma who are starting treatment with encorafenib and binimetinib. Instead of a controlled trial, it observes how these drugs work in real-world settings, focusing on patients' quality of life ove…
Sponsor: Pierre Fabre Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC